Although Utah is a low-incidence tuberculosis (TB) state, the state has faced the challenge of managing an increasing number of cases of multidrug-resistant tuberculosis (MDR TB) in the past several years. MDR TB is defined as cases of TB disease in persons whose ''Mycobacterium tuberculosis'' isolates are resistant to at least isoniazid and rifampin, the two most effective TB medications. This makes treatment of MDR TB more difficult, prolonged, and costly. Treatment of MDR TB can last up to 24 months. The state had four cases of MDR TB reported from 2012 to 2016.
Prevention, Treatment, and Care Program, Bureau of Epidemiology, Division of Disease Control and Prevention, Utah Department of Health, Salt Lake City, UT 84114-2104, Telephone: 801-538-6191, Fax: 801-538-9913, Website: http://www.health.utah.gov/epi/diseases/TB, Contact: Amelia Self, Program Manager; Jerry Carlile, Epidemiologist, email: aself@utah.gov, jcarlile@utah.gov
The information provided above is from the Department of Health's Center for
Health Data IBIS-PH web site (http://ibis.health.state.gov). The information published
on this website may be reproduced without permission. Please use the following citation:
"
Retrieved
Fri, 20 April 2018 14:19:13
from Department of Health, Center for Health Data, Indicator-Based Information
System for Public Health Web site: http://ibis.health.state.gov
".
